Bristol Myers Squibb eyes 600,000-square-foot plant in northeast Harris County

Bristol Myers Squibb is weighing a major manufacturing footprint in northeast Harris County that could turn a stretch of Generation Park into a new pharmaceutical production base, but the plan remains only a proposal. The company’s application, filed with the Texas Comptroller as Project Argonaut, outlines an initial 600,000-square-foot campus on Aqueduct Road between Lake Houston Parkway and Garrett Road, with room to expand far beyond the first phase.

The filing estimates 489 new jobs in Texas, with annual average wages of about $96,000. The mix would include operations technicians, production specialists, maintenance support, quality control, engineering, product development, administration and management. The application says the site would begin construction in 2027 and wrap in 2029, and it would rely primarily on trucks to move feedstock and finished medicines.

That matters for Harris County because the project is being framed not as a single plant, but as the foundation for a longer-term pharmaceutical campus. The application says the modular design is meant to allow expandable growth, and Bristol Myers Squibb is also shortlisting 16 sites in three states as it evaluates where to locate new domestic manufacturing investment. The company’s broader strategy points to a national competition for high-wage life-sciences jobs, not a done deal for Houston.

If the company moves ahead in northeast Houston, the public tradeoffs could be significant. Bristol Myers Squibb is seeking help through Texas’ JETI program, which can provide up to a 10-year school district maintenance-and-operations tax limitation if the Governor and the local district approve it. Under JETI rules, the company must show the incentive is a compelling factor in choosing the site and that the project is likely to generate enough tax revenue over 20 years to offset the tax break.

Sheldon Independent School District would be on the hook for that side of the deal. The district had 10,921 students in 2024-25, an overall state rating of C, or 77 out of 100, and 82.4% of students were economically disadvantaged. Those numbers will shape how local leaders weigh the promise of new jobs against the loss of school tax revenue.

The Bristol Myers Squibb filing also arrives as Generation Park tries to establish itself as a biomanufacturing cluster. McCord Development says the 4,300-acre project already includes BioHub Two, a 45-acre campus with about 500,000 square feet planned for cGMP manufacturing, lab and office space, plus nearly $30 million in infrastructure nearing completion. McCord has also partnered with San Jacinto College and NIBRT on the Center for Biotechnology at Generation Park.

Houston has already landed a much larger prize nearby: Eli Lilly chose Generation Park in September 2025 for a $6.5 billion pharmaceutical manufacturing facility expected to create more than 615 full-time jobs and more than 4,000 construction jobs. Together, the Lilly win and the Bristol Myers Squibb proposal suggest northeast Harris County could be emerging as a serious manufacturing hub, if the projects survive incentives, infrastructure demands and the final site-selection fight.